(Q33638239)

28 July 2017

1 reference

title

Realistic expectations for the management of Alzheimer's disease (English)

1 reference

28 July 2017

0 references

Brodaty H

1

1 reference

PubMed ID

10332934

28 July 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

European Neuropsychopharmacology

28 July 2017

1 reference

28 July 2017

9 Suppl 2

1 reference

28 July 2017

S43-52

1 reference

Use of genetically engineered mice as models for understanding human neurodegenerative disease.

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?: The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Medical history and the risk of Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Effect of a training programme to reduce stress in carers of patients with dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Cost effectiveness of a training program for dementia carers.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Psychological morbidity in caregivers is associated with depression in patients with dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Time until institutionalization and death in patients with dementia. Role of caregiver training and risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

The Prince Henry Hospital dementia caregivers' training programme.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

A case-control study of Alzheimer's disease in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Reliability of the Washington University Clinical Dementia Rating.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Neuropsychiatric aspects of Alzheimer's disease: the cholinergic hypothesis revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Level of education and change in cognitive function in a community population of older persons.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Depression, cognition, and functional ability in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XI. Clinical milestones in patients with Alzheimer's disease followed over 3 years

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

A meta-analytic review of interventions for caregiver distress: recommendations for future research

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Lewy bodies and response to tacrine in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Apolipoprotein E4 allele and Alzheimer disease: examination of allelic association and effect on age at onset in both early- and late-onset cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Development of a national prospective study of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

An intervention that delays institutionalization of Alzheimer's disease patients: treatment of spouse-caregivers.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Incontinence and troublesome behaviors predict institutionalization in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Estrogen deficiency and risk of Alzheimer's disease in women.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Desamino-D-arginine-vasopressin (DDAVP) in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Double-blind trial of imipramine in Alzheimer's disease patients with and without depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Estrogen replacement therapy and memory in older women

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Alzheimer's disease: genotypes, phenotypes, and treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Influence of education and occupation on the incidence of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Behavioral treatment of depression in dementia patients: a controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900044-3

7 January 2021

10.1016/S0924-977X(98)00044-3

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10332934